JP2015527875A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015527875A5 JP2015527875A5 JP2015516469A JP2015516469A JP2015527875A5 JP 2015527875 A5 JP2015527875 A5 JP 2015527875A5 JP 2015516469 A JP2015516469 A JP 2015516469A JP 2015516469 A JP2015516469 A JP 2015516469A JP 2015527875 A5 JP2015527875 A5 JP 2015527875A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleotide sequence
- st6galnac3
- c1orf114
- hapln3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201270326 | 2012-06-14 | ||
| DKPA201270326 | 2012-06-14 | ||
| PCT/DK2013/050196 WO2013185779A2 (en) | 2012-06-14 | 2013-06-14 | Biomarkers for prostate cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015527875A JP2015527875A (ja) | 2015-09-24 |
| JP2015527875A5 true JP2015527875A5 (https=) | 2016-07-07 |
| JP6242388B2 JP6242388B2 (ja) | 2017-12-06 |
Family
ID=48740787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516469A Active JP6242388B2 (ja) | 2012-06-14 | 2013-06-14 | 前立腺ガンのバイオマーカー |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10106854B2 (https=) |
| EP (1) | EP2861759B1 (https=) |
| JP (1) | JP6242388B2 (https=) |
| AU (1) | AU2013275761B2 (https=) |
| CA (1) | CA2876252A1 (https=) |
| WO (1) | WO2013185779A2 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2859645T3 (es) | 2013-03-14 | 2021-10-04 | Mayo Found Medical Education & Res | Detección de neoplasia |
| EP3037545A1 (en) * | 2014-12-23 | 2016-06-29 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin | A DNA-methylation test for prostate cancer |
| CN107532124B (zh) | 2015-03-27 | 2022-08-09 | 精密科学公司 | 检测食管疾病 |
| CN108138235B (zh) | 2015-08-31 | 2022-04-15 | 梅约医药教育及研究基金会 | 检测胃肿瘤 |
| CN106480169B (zh) * | 2015-09-01 | 2019-10-08 | 杨小丽 | 人aqp10和sox17基因甲基化位点的检测和应用 |
| CN110431241B (zh) | 2017-02-28 | 2024-04-19 | 梅约医学教育与研究基金会 | 检测前列腺癌 |
| GB201816820D0 (en) | 2018-10-16 | 2018-11-28 | Univ York | Diagnostic method |
| EP3880846B1 (en) | 2018-11-13 | 2024-08-28 | Bracco Imaging SPA | Gene signatures for the prediction of prostate cancer recurrence |
| CN109468381B (zh) * | 2018-11-19 | 2022-11-25 | 兰州市第一人民医院 | 用于宫颈癌筛查的甲基化位点及其检测引物 |
| EP3999662A1 (en) * | 2019-07-19 | 2022-05-25 | Vilnius University | Characterization of prostate cancer using dna methylation assay system |
| CN113122636A (zh) * | 2020-01-14 | 2021-07-16 | 上海鹍远生物技术有限公司 | 检测dna甲基化的试剂及用途 |
| EP4146678A4 (en) * | 2020-05-04 | 2025-08-27 | Mayo Found Medical Education & Res | DETECTION OF PANCREATIC NEUROENDOCRINE TUMORS |
| WO2021226110A1 (en) * | 2020-05-05 | 2021-11-11 | The Board Of Trustees Of The Leland Stanford Junior University | Cell-free dna biomarkers and their use in diagnosis, monitoring response to therapy, and selection of therapy for prostate cancer |
| CN118685523B (zh) * | 2024-08-26 | 2024-11-15 | 湖南宏雅基因技术有限公司 | 一种用于前列腺癌检测的生物标志物组合、引物探针组合物及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5786146A (en) | 1996-06-03 | 1998-07-28 | The Johns Hopkins University School Of Medicine | Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids |
| US6605432B1 (en) | 1999-02-05 | 2003-08-12 | Curators Of The University Of Missouri | High-throughput methods for detecting DNA methylation |
| US20020137086A1 (en) * | 2001-03-01 | 2002-09-26 | Alexander Olek | Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylation status of the genes |
| US20100297067A1 (en) * | 2007-05-14 | 2010-11-25 | The Johns Hopkins University | Methylation markers for prostate cancer and methods of use |
| WO2010017301A1 (en) * | 2008-08-05 | 2010-02-11 | Veridex, Llc | Prostate cancer methylation assay |
| KR20110111462A (ko) * | 2009-01-07 | 2011-10-11 | 미리어드 제네틱스, 인크. | 암 바이오마커 |
| US20100303795A1 (en) | 2009-05-27 | 2010-12-02 | Soerensen Karina Dalsgaard | Marker of prostate cancer |
| WO2011027310A1 (en) * | 2009-09-03 | 2011-03-10 | Koninklijke Philips Electronics N.V. | Novel tumor markers |
| WO2011037936A2 (en) * | 2009-09-24 | 2011-03-31 | Oregon Health & Science University | Detection of dna methylation of tal1, erg and/or cd40 to diagnose prostate cancer |
| WO2011044902A1 (en) | 2009-10-13 | 2011-04-21 | Aarhus Universitet | Tff3 hypomethylation as a novel biomarker for prostate cancer |
| US20110223180A1 (en) * | 2010-03-11 | 2011-09-15 | Aldape Kenneth D | Methods and compositions related to a multi-methylation assay to predict patient outcome |
| WO2012138609A2 (en) * | 2011-04-04 | 2012-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Methylation biomarkers for diagnosis of prostate cancer |
-
2013
- 2013-06-14 US US14/407,541 patent/US10106854B2/en active Active
- 2013-06-14 JP JP2015516469A patent/JP6242388B2/ja active Active
- 2013-06-14 WO PCT/DK2013/050196 patent/WO2013185779A2/en not_active Ceased
- 2013-06-14 AU AU2013275761A patent/AU2013275761B2/en active Active
- 2013-06-14 EP EP13732819.1A patent/EP2861759B1/en active Active
- 2013-06-14 CA CA2876252A patent/CA2876252A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015527875A5 (https=) | ||
| JP6721665B2 (ja) | 目的遺伝子発現の線形結合を用いた細胞信号伝達経路活性の評価 | |
| Zhang et al. | Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling | |
| JP6246845B2 (ja) | 遺伝子発現を用いた前立腺癌の予後を定量化する方法 | |
| CN103733065B (zh) | 用于癌症的分子诊断试验 | |
| RU2718647C2 (ru) | Медицинский прогноз и предсказание результатов лечения, используя активности множества клеточных сигнальных путей | |
| AU2011302004B2 (en) | Molecular diagnostic test for cancer | |
| Liu et al. | Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer | |
| CN114594259B (zh) | 一种新型的用于结直肠癌预后预测和诊断的模型及其应用 | |
| CN105874079A (zh) | 用于肺癌的分子诊断测试 | |
| JP2011500071A (ja) | 遺伝子に基づくアルゴリズム的ガン予後及び患者の臨床結果 | |
| WO2015033172A1 (en) | Molecular diagnostic test for oesophageal cancer | |
| CN101173313B (zh) | 乳腺癌转移和预后分子分型基因群及其基因芯片制备和应用方法 | |
| US20240352530A1 (en) | Circulating microrna panel for the early detection of breast cancer and methods thereof | |
| EP3444362A2 (en) | Circulating mirnas as early detection marker and prognostic marker | |
| CN113736879A (zh) | 用于小细胞肺癌患者预后的系统及其应用 | |
| Azadeh et al. | Decreased expression level of long non-coding RNA CCAT1, was observed in breast cancer tissue of an Isfahanian population (Iran) | |
| CN108728534A (zh) | 4-LncRNA分子标签用于肝癌预后评估的试剂盒 | |
| US20180135130A1 (en) | Novel methylation site regulating expression of mda-9/syntenin | |
| CN112063714A (zh) | 一种与结直肠癌相关的miRNA及其应用 | |
| WO2014111561A1 (en) | Serum mirna-142-3p as prognostic cancer marker | |
| JP2020528733A (ja) | 肝細胞癌（ｈｃｃ）または胆管癌（ｃｃａ）を有する被験者の生存転帰を予測する方法 | |
| CN113826166A (zh) | 评估气道上皮细胞中的多信号传导途径活性评分以预测气道上皮异常和气道癌风险 | |
| US20240093306A1 (en) | Micro rna liver cancer markers and uses thereof | |
| JP2024507775A (ja) | 乳がんの診断のためのバイオマーカー |